Target intelligence / Profile preview

Tick proteins

Molecular classification
Enzyme, Receptor, Ion channel, Structural protein, Transcription factor, Other
01

Overview

Tick proteins refers to a broad and diverse group of proteins produced by ticks (Ixodida) that are essential for their survival, feeding, and role as disease vectors. These proteins are primarily found in the tick's saliva, midgut, and cement, and they perform critical functions such as inhibiting host hemostasis, modulating host immune responses, and facilitating the transmission of pathogens like Borrelia burgdorferi (Lyme disease) and Tick-borne encephalitis virus [2, 6, 12]. In the field of drug and vaccine development, specific tick proteins are targeted to disrupt the tick life cycle or prevent disease transmission; for example, the gut protein BM86 and the conserved protein Subolesin are used as antigens in anti-tick vaccines to induce host antibodies that impair tick feeding and reproduction [6, 9]. Furthermore, tick proteins such as GABA-gated chloride channels and Octopamine receptors are the molecular targets of acaricides and newer systemic agents like isoxazolines (e.g., Lotilaner, Sarolaner) [14]. While tick-derived proteins are also being investigated as a source of novel human therapeutics (e.g., anticoagulants and anti-inflammatories), in those instances, the tick proteins serve as the drug candidates rather than the therapeutic targets [1, 5, 10].

Other names
Anti-tick vaccine antigensTick salivary proteinsTick gut proteinsTick-derived antigensTick bioactive molecules
02

Mechanism of action

Vaccines induce host antibodies that bind to tick proteins, disrupting feeding, reproduction, or pathogen transmission; acaricides and isoxazolines act as inhibitors or modulators of essential tick enzymes, receptors, or ion channels (e.g., GABA-gated chloride channels).

03

Biological functions

Immune responseCell signalingMetabolismAdhesionPathogen transmissionOther
04

Disease associations

InfectionInflammationOther
05

Safety considerations

Cross-reactivity with host orthologsAllergic reactions to tick antigensDevelopment of resistance in tick populationsSpecies-specific efficacy limitations
06

Interacting drugs

Gavac

8 more in the full profile.

07

Biomarkers

Anti-tick protein antibody titersTick attachment rateTick engorgement weightPathogen transmission rate

Beyond the preview

Go deeper on Tick proteins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tick proteins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call